Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
15/08/2025 | Fullerton Fund Investments Pte Ltd | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
15/08/2025 | WANG QINGHUA | 1701(L) | +30,319,624(L) | 30,319,624(L) | 82.99 | |
15/08/2025 | Guangzhou Nuosu Enterprise Management Partnership (Limited Partnership) | 1701(L) | +23,168,082(L) | 23,168,082(L) | 5.51 | |
15/08/2025 | Linden Investments Pte. Ltd. | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
15/08/2025 | Pavilion Capital GP Pte. Ltd. | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
15/08/2025 | Palace Investments Pte. Ltd. | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
15/08/2025 | CICC Biomedical Fund L.P. | 1701(L) | 2,353,008(L) | 2,353,008(L) | 6.44 | |
15/08/2025 | Henan Zhongjin Huirong Private Equity Fund Management Co., Ltd. | 1701(L) | 2,353,008(L) | 2,353,008(L) | 6.44 | |
15/08/2025 | Shanghai Nuotang Biotechnology Co., Ltd. | 1701(L) | +13,074,949(L) | 13,074,949(L) | 35.79 | |
15/08/2025 | China International Capital Corporation Limited | 1701(L) | 2,353,008(L) | 2,353,008(L) | 6.44 | |
15/08/2025 | Temasek Holdings (Private) Limited | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
15/08/2025 | WANG QINGHUA | 1701(L) | +121,278,502(L) | 121,278,502(L) | 28.86 | |
15/08/2025 | 1701(L) | 2,353,008(L) | 2,353,008(L) | 6.44 | ||
15/08/2025 | Shanghai Nuotang Biotechnology Co., Ltd. | 1701(L) | +52,299,799(L) | 52,299,799(L) | 12.44 | |
15/08/2025 | PavCap Fund I | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
15/08/2025 | PavCap I Feeder No. 1 LP | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
15/08/2025 | Pavilion Capital Holdings Pte. Ltd. | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
15/08/2025 | Guangzhou Nuopa Enterprise Management Partnership (Limited Partnership) | 1701(L) | +26,219,717(L) | 26,219,717(L) | 6.24 | |
15/08/2025 | Hong Kong Invengen Pharmaceutical Technology Co., Limited | 1701(L) | +30,319,624(L) | 30,319,624(L) | 82.99 | |
15/08/2025 | Guangzhou Nuosu Enterprise Management Partnership (Limited Partnership) | 1701(L) | +5,792,020(L) | 5,792,020(L) | 15.85 | |
15/08/2025 | Guangzhou Nuopa Enterprise Management Partnership (Limited Partnership) | 1701(L) | +6,554,929(L) | 6,554,929(L) | 17.94 | |
15/08/2025 | Hong Kong Invengen Pharmaceutical Technology Co., Limited | 1701(L) | +121,278,502(L) | 121,278,502(L) | 28.56 | |
15/08/2025 | Hong Kong Innogen Pharmaceutical Technology Co., Limited | 1701(L) | +2,550,044(L) | 2,550,044(L) | 6.98 | |
1 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 11/09/2025 17:59 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |